nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—SLC22A3—Vincristine—sarcoma	0.164	0.196	CbGbCtD
Prazosin—CYP1A1—Dacarbazine—sarcoma	0.124	0.148	CbGbCtD
Prazosin—ABCG2—Dactinomycin—sarcoma	0.116	0.139	CbGbCtD
Prazosin—ABCG2—Mitoxantrone—sarcoma	0.104	0.125	CbGbCtD
Prazosin—ABCG2—Vincristine—sarcoma	0.0716	0.0858	CbGbCtD
Prazosin—ABCG2—Etoposide—sarcoma	0.0656	0.0786	CbGbCtD
Prazosin—ABCG2—Doxorubicin—sarcoma	0.0447	0.0536	CbGbCtD
Prazosin—ABCB1—Dactinomycin—sarcoma	0.0419	0.0502	CbGbCtD
Prazosin—ABCB1—Mitoxantrone—sarcoma	0.0375	0.0449	CbGbCtD
Prazosin—ABCB1—Vincristine—sarcoma	0.0258	0.0309	CbGbCtD
Prazosin—ABCB1—Etoposide—sarcoma	0.0236	0.0283	CbGbCtD
Prazosin—HTR1D—meninx—sarcoma	0.0196	0.235	CbGeAlD
Prazosin—HTR1D—dura mater—sarcoma	0.018	0.216	CbGeAlD
Prazosin—ABCB1—Doxorubicin—sarcoma	0.0161	0.0193	CbGbCtD
Prazosin—MT3—testis—sarcoma	0.0022	0.0264	CbGeAlD
Prazosin—KCNH7—testis—sarcoma	0.0022	0.0264	CbGeAlD
Prazosin—KCNH6—uterus—sarcoma	0.00216	0.0259	CbGeAlD
Prazosin—Cataract—Thiotepa—sarcoma	0.0016	0.0203	CcSEcCtD
Prazosin—MT3—lymph node—sarcoma	0.00159	0.0191	CbGeAlD
Prazosin—SLC22A3—myometrium—sarcoma	0.00133	0.0159	CbGeAlD
Prazosin—ORM1—hematopoietic system—sarcoma	0.00131	0.0156	CbGeAlD
Prazosin—SLC22A3—embryo—sarcoma	0.00128	0.0153	CbGeAlD
Prazosin—SLC22A3—seminal vesicle—sarcoma	0.0012	0.0144	CbGeAlD
Prazosin—SLC22A3—hematopoietic system—sarcoma	0.00114	0.0137	CbGeAlD
Prazosin—HTR1D—connective tissue—sarcoma	0.00114	0.0137	CbGeAlD
Prazosin—SLC22A3—connective tissue—sarcoma	0.0011	0.0132	CbGeAlD
Prazosin—KCNH2—myometrium—sarcoma	0.00102	0.0123	CbGeAlD
Prazosin—SLC22A3—smooth muscle tissue—sarcoma	0.00101	0.0121	CbGeAlD
Prazosin—HTR1A—hematopoietic system—sarcoma	0.000987	0.0118	CbGeAlD
Prazosin—KCNH2—seminal vesicle—sarcoma	0.000925	0.0111	CbGeAlD
Prazosin—ABCG2—myometrium—sarcoma	0.000911	0.0109	CbGeAlD
Prazosin—ADRA1A—hematopoietic system—sarcoma	0.00091	0.0109	CbGeAlD
Prazosin—KCNH2—hematopoietic system—sarcoma	0.000879	0.0105	CbGeAlD
Prazosin—ORM1—bone marrow—sarcoma	0.000837	0.01	CbGeAlD
Prazosin—ABCG2—seminal vesicle—sarcoma	0.000823	0.00986	CbGeAlD
Prazosin—ADRA2A—myometrium—sarcoma	0.000806	0.00966	CbGeAlD
Prazosin—Sweating increased—Mitoxantrone—sarcoma	0.000804	0.0102	CcSEcCtD
Prazosin—Epistaxis—Thiotepa—sarcoma	0.000804	0.0102	CcSEcCtD
Prazosin—Erectile dysfunction—Vincristine—sarcoma	0.00078	0.00991	CcSEcCtD
Prazosin—Hallucination—Thiotepa—sarcoma	0.000761	0.00966	CcSEcCtD
Prazosin—Erectile dysfunction—Mitoxantrone—sarcoma	0.00076	0.00965	CcSEcCtD
Prazosin—CYP1A1—hematopoietic system—sarcoma	0.000742	0.00889	CbGeAlD
Prazosin—Drowsiness—Mitoxantrone—sarcoma	0.000736	0.00934	CcSEcCtD
Prazosin—ADRA2A—seminal vesicle—sarcoma	0.000728	0.00872	CbGeAlD
Prazosin—Tinnitus—Thiotepa—sarcoma	0.000713	0.00905	CcSEcCtD
Prazosin—Flushing—Dactinomycin—sarcoma	0.000705	0.00895	CcSEcCtD
Prazosin—ADRA2A—hematopoietic system—sarcoma	0.000692	0.00829	CbGeAlD
Prazosin—ORM1—liver—sarcoma	0.000676	0.0081	CbGeAlD
Prazosin—Alopecia—Thiotepa—sarcoma	0.000676	0.00858	CcSEcCtD
Prazosin—Hallucination—Vincristine—sarcoma	0.000675	0.00857	CcSEcCtD
Prazosin—Bradycardia—Mitoxantrone—sarcoma	0.000672	0.00854	CcSEcCtD
Prazosin—Alopecia—Dactinomycin—sarcoma	0.000671	0.00852	CcSEcCtD
Prazosin—Sweating increased—Etoposide—sarcoma	0.000669	0.00849	CcSEcCtD
Prazosin—KCNH2—cardiac atrium—sarcoma	0.000667	0.008	CbGeAlD
Prazosin—ADRA2A—connective tissue—sarcoma	0.000666	0.00798	CbGeAlD
Prazosin—KCNH2—uterus—sarcoma	0.000664	0.00796	CbGeAlD
Prazosin—Tension—Thiotepa—sarcoma	0.000653	0.0083	CcSEcCtD
Prazosin—Nervousness—Thiotepa—sarcoma	0.000647	0.00821	CcSEcCtD
Prazosin—CYP1A1—skin of body—sarcoma	0.000645	0.00773	CbGeAlD
Prazosin—ADRA1A—lymphoid tissue—sarcoma	0.000641	0.00768	CbGeAlD
Prazosin—Vision blurred—Thiotepa—sarcoma	0.000628	0.00797	CcSEcCtD
Prazosin—SLC22A3—testis—sarcoma	0.000626	0.0075	CbGeAlD
Prazosin—SLC22A1—liver—sarcoma	0.000619	0.00742	CbGeAlD
Prazosin—Ill-defined disorder—Dactinomycin—sarcoma	0.000613	0.00779	CcSEcCtD
Prazosin—Alopecia—Vincristine—sarcoma	0.000599	0.00761	CcSEcCtD
Prazosin—Malaise—Dactinomycin—sarcoma	0.000596	0.00757	CcSEcCtD
Prazosin—SLC22A3—liver—sarcoma	0.000592	0.00709	CbGeAlD
Prazosin—ABCG2—uterus—sarcoma	0.000591	0.00708	CbGeAlD
Prazosin—Alopecia—Mitoxantrone—sarcoma	0.000584	0.00741	CcSEcCtD
Prazosin—Arthralgia—Thiotepa—sarcoma	0.000567	0.0072	CcSEcCtD
Prazosin—CYP1A1—cardiac atrium—sarcoma	0.000564	0.00675	CbGeAlD
Prazosin—KCNH2—bone marrow—sarcoma	0.000563	0.00675	CbGeAlD
Prazosin—CYP1A1—uterus—sarcoma	0.000561	0.00672	CbGeAlD
Prazosin—Discomfort—Dactinomycin—sarcoma	0.000556	0.00706	CcSEcCtD
Prazosin—Vision blurred—Mitoxantrone—sarcoma	0.000542	0.00688	CcSEcCtD
Prazosin—Oedema—Dactinomycin—sarcoma	0.000539	0.00685	CcSEcCtD
Prazosin—Ill-defined disorder—Mitoxantrone—sarcoma	0.000534	0.00677	CcSEcCtD
Prazosin—Vertigo—Vincristine—sarcoma	0.00053	0.00674	CcSEcCtD
Prazosin—Tachycardia—Thiotepa—sarcoma	0.00053	0.00673	CcSEcCtD
Prazosin—ADRA2A—cardiac atrium—sarcoma	0.000525	0.0063	CbGeAlD
Prazosin—ADRA2A—uterus—sarcoma	0.000523	0.00626	CbGeAlD
Prazosin—Malaise—Mitoxantrone—sarcoma	0.000519	0.00658	CcSEcCtD
Prazosin—ORM1—lymph node—sarcoma	0.000518	0.00621	CbGeAlD
Prazosin—Flushing—Etoposide—sarcoma	0.00051	0.00647	CcSEcCtD
Prazosin—ABCG2—bone marrow—sarcoma	0.000501	0.00601	CbGeAlD
Prazosin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000495	0.00629	CcSEcCtD
Prazosin—Eye pain—Epirubicin—sarcoma	0.000493	0.00626	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000491	0.00624	CcSEcCtD
Prazosin—Arthralgia—Mitoxantrone—sarcoma	0.00049	0.00622	CcSEcCtD
Prazosin—Paraesthesia—Thiotepa—sarcoma	0.000488	0.0062	CcSEcCtD
Prazosin—Alopecia—Etoposide—sarcoma	0.000486	0.00616	CcSEcCtD
Prazosin—Discomfort—Mitoxantrone—sarcoma	0.000484	0.00614	CcSEcCtD
Prazosin—Somnolence—Thiotepa—sarcoma	0.000483	0.00613	CcSEcCtD
Prazosin—Oedema—Vincristine—sarcoma	0.000482	0.00612	CcSEcCtD
Prazosin—KCNH2—testis—sarcoma	0.000482	0.00577	CbGeAlD
Prazosin—ADRA1A—liver—sarcoma	0.000472	0.00565	CbGeAlD
Prazosin—Oedema—Mitoxantrone—sarcoma	0.000469	0.00596	CcSEcCtD
Prazosin—Fatigue—Thiotepa—sarcoma	0.000469	0.00595	CcSEcCtD
Prazosin—Hyperhidrosis—Vincristine—sarcoma	0.000466	0.00591	CcSEcCtD
Prazosin—Fatigue—Dactinomycin—sarcoma	0.000465	0.0059	CcSEcCtD
Prazosin—Constipation—Thiotepa—sarcoma	0.000465	0.0059	CcSEcCtD
Prazosin—Pain—Thiotepa—sarcoma	0.000465	0.0059	CcSEcCtD
Prazosin—Shock—Mitoxantrone—sarcoma	0.000462	0.00586	CcSEcCtD
Prazosin—Pain—Dactinomycin—sarcoma	0.000461	0.00586	CcSEcCtD
Prazosin—Tachycardia—Mitoxantrone—sarcoma	0.000458	0.00582	CcSEcCtD
Prazosin—ADRA2A—tendon—sarcoma	0.000458	0.00549	CbGeAlD
Prazosin—Eye pain—Doxorubicin—sarcoma	0.000456	0.00579	CcSEcCtD
Prazosin—SLC22A3—lymph node—sarcoma	0.000454	0.00544	CbGeAlD
Prazosin—Hyperhidrosis—Mitoxantrone—sarcoma	0.000454	0.00576	CcSEcCtD
Prazosin—ABCB1—myometrium—sarcoma	0.000449	0.00538	CbGeAlD
Prazosin—Feeling abnormal—Thiotepa—sarcoma	0.000448	0.00569	CcSEcCtD
Prazosin—Feeling abnormal—Dactinomycin—sarcoma	0.000444	0.00564	CcSEcCtD
Prazosin—Ill-defined disorder—Etoposide—sarcoma	0.000444	0.00563	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Vincristine—sarcoma	0.000439	0.00557	CcSEcCtD
Prazosin—Insomnia—Vincristine—sarcoma	0.000436	0.00553	CcSEcCtD
Prazosin—Paraesthesia—Vincristine—sarcoma	0.000433	0.00549	CcSEcCtD
Prazosin—ABCB1—embryo—sarcoma	0.000432	0.00518	CbGeAlD
Prazosin—Urticaria—Thiotepa—sarcoma	0.000432	0.00548	CcSEcCtD
Prazosin—Malaise—Etoposide—sarcoma	0.000431	0.00548	CcSEcCtD
Prazosin—Vertigo—Etoposide—sarcoma	0.00043	0.00546	CcSEcCtD
Prazosin—Body temperature increased—Thiotepa—sarcoma	0.00043	0.00545	CcSEcCtD
Prazosin—ABCG2—testis—sarcoma	0.000429	0.00513	CbGeAlD
Prazosin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000428	0.00543	CcSEcCtD
Prazosin—Body temperature increased—Dactinomycin—sarcoma	0.000426	0.00541	CcSEcCtD
Prazosin—Paraesthesia—Mitoxantrone—sarcoma	0.000421	0.00535	CcSEcCtD
Prazosin—Loss of consciousness—Etoposide—sarcoma	0.00042	0.00534	CcSEcCtD
Prazosin—Dyspnoea—Mitoxantrone—sarcoma	0.000418	0.00531	CcSEcCtD
Prazosin—Somnolence—Mitoxantrone—sarcoma	0.000417	0.0053	CcSEcCtD
Prazosin—Fatigue—Vincristine—sarcoma	0.000415	0.00527	CcSEcCtD
Prazosin—Constipation—Vincristine—sarcoma	0.000412	0.00523	CcSEcCtD
Prazosin—Pain—Vincristine—sarcoma	0.000412	0.00523	CcSEcCtD
Prazosin—Orthostatic hypotension—Epirubicin—sarcoma	0.000407	0.00516	CcSEcCtD
Prazosin—ABCB1—seminal vesicle—sarcoma	0.000406	0.00486	CbGeAlD
Prazosin—ABCG2—liver—sarcoma	0.000405	0.00485	CbGeAlD
Prazosin—Fatigue—Mitoxantrone—sarcoma	0.000405	0.00514	CcSEcCtD
Prazosin—Discomfort—Etoposide—sarcoma	0.000402	0.00511	CcSEcCtD
Prazosin—Constipation—Mitoxantrone—sarcoma	0.000401	0.0051	CcSEcCtD
Prazosin—Pain—Mitoxantrone—sarcoma	0.000401	0.0051	CcSEcCtD
Prazosin—Hypersensitivity—Thiotepa—sarcoma	0.0004	0.00508	CcSEcCtD
Prazosin—Hypersensitivity—Dactinomycin—sarcoma	0.000397	0.00505	CcSEcCtD
Prazosin—Asthenia—Thiotepa—sarcoma	0.00039	0.00495	CcSEcCtD
Prazosin—Asthenia—Dactinomycin—sarcoma	0.000387	0.00491	CcSEcCtD
Prazosin—Feeling abnormal—Mitoxantrone—sarcoma	0.000387	0.00491	CcSEcCtD
Prazosin—ABCB1—hematopoietic system—sarcoma	0.000386	0.00462	CbGeAlD
Prazosin—CYP1A1—liver—sarcoma	0.000385	0.00461	CbGeAlD
Prazosin—Pruritus—Thiotepa—sarcoma	0.000384	0.00488	CcSEcCtD
Prazosin—Tachycardia—Etoposide—sarcoma	0.000381	0.00484	CcSEcCtD
Prazosin—Body temperature increased—Vincristine—sarcoma	0.000381	0.00484	CcSEcCtD
Prazosin—ADRA2A—testis—sarcoma	0.000379	0.00454	CbGeAlD
Prazosin—Hyperhidrosis—Etoposide—sarcoma	0.000377	0.00479	CcSEcCtD
Prazosin—Pancreatitis—Epirubicin—sarcoma	0.000377	0.00479	CcSEcCtD
Prazosin—Orthostatic hypotension—Doxorubicin—sarcoma	0.000376	0.00478	CcSEcCtD
Prazosin—Angina pectoris—Epirubicin—sarcoma	0.000375	0.00476	CcSEcCtD
Prazosin—Urticaria—Mitoxantrone—sarcoma	0.000373	0.00473	CcSEcCtD
Prazosin—Diarrhoea—Thiotepa—sarcoma	0.000372	0.00472	CcSEcCtD
Prazosin—Body temperature increased—Mitoxantrone—sarcoma	0.000371	0.00471	CcSEcCtD
Prazosin—Diarrhoea—Dactinomycin—sarcoma	0.000369	0.00469	CcSEcCtD
Prazosin—Dizziness—Thiotepa—sarcoma	0.000359	0.00456	CcSEcCtD
Prazosin—Pollakiuria—Epirubicin—sarcoma	0.000355	0.00451	CcSEcCtD
Prazosin—Hypersensitivity—Vincristine—sarcoma	0.000355	0.00451	CcSEcCtD
Prazosin—Paraesthesia—Etoposide—sarcoma	0.000351	0.00445	CcSEcCtD
Prazosin—KCNH2—lymph node—sarcoma	0.000349	0.00418	CbGeAlD
Prazosin—Pancreatitis—Doxorubicin—sarcoma	0.000349	0.00443	CcSEcCtD
Prazosin—Dyspnoea—Etoposide—sarcoma	0.000348	0.00442	CcSEcCtD
Prazosin—Somnolence—Etoposide—sarcoma	0.000347	0.00441	CcSEcCtD
Prazosin—Angina pectoris—Doxorubicin—sarcoma	0.000347	0.0044	CcSEcCtD
Prazosin—Hypersensitivity—Mitoxantrone—sarcoma	0.000346	0.00439	CcSEcCtD
Prazosin—Asthenia—Vincristine—sarcoma	0.000346	0.00439	CcSEcCtD
Prazosin—Vomiting—Thiotepa—sarcoma	0.000346	0.00439	CcSEcCtD
Prazosin—Drowsiness—Epirubicin—sarcoma	0.000343	0.00436	CcSEcCtD
Prazosin—Vomiting—Dactinomycin—sarcoma	0.000343	0.00435	CcSEcCtD
Prazosin—Rash—Thiotepa—sarcoma	0.000343	0.00435	CcSEcCtD
Prazosin—Dermatitis—Thiotepa—sarcoma	0.000342	0.00435	CcSEcCtD
Prazosin—Headache—Thiotepa—sarcoma	0.00034	0.00432	CcSEcCtD
Prazosin—Rash—Dactinomycin—sarcoma	0.00034	0.00432	CcSEcCtD
Prazosin—Asthenia—Mitoxantrone—sarcoma	0.000337	0.00428	CcSEcCtD
Prazosin—Fatigue—Etoposide—sarcoma	0.000337	0.00427	CcSEcCtD
Prazosin—Constipation—Etoposide—sarcoma	0.000334	0.00424	CcSEcCtD
Prazosin—Pain—Etoposide—sarcoma	0.000334	0.00424	CcSEcCtD
Prazosin—Diarrhoea—Vincristine—sarcoma	0.00033	0.00419	CcSEcCtD
Prazosin—Pollakiuria—Doxorubicin—sarcoma	0.000329	0.00418	CcSEcCtD
Prazosin—Epistaxis—Epirubicin—sarcoma	0.000324	0.00411	CcSEcCtD
Prazosin—Nausea—Thiotepa—sarcoma	0.000323	0.0041	CcSEcCtD
Prazosin—Feeling abnormal—Etoposide—sarcoma	0.000322	0.00408	CcSEcCtD
Prazosin—Diarrhoea—Mitoxantrone—sarcoma	0.000321	0.00408	CcSEcCtD
Prazosin—Nausea—Dactinomycin—sarcoma	0.00032	0.00407	CcSEcCtD
Prazosin—Dizziness—Vincristine—sarcoma	0.000319	0.00405	CcSEcCtD
Prazosin—Drowsiness—Doxorubicin—sarcoma	0.000317	0.00403	CcSEcCtD
Prazosin—Bradycardia—Epirubicin—sarcoma	0.000314	0.00398	CcSEcCtD
Prazosin—ABCG2—lymph node—sarcoma	0.000311	0.00372	CbGeAlD
Prazosin—Urticaria—Etoposide—sarcoma	0.00031	0.00394	CcSEcCtD
Prazosin—Body temperature increased—Etoposide—sarcoma	0.000309	0.00392	CcSEcCtD
Prazosin—Vomiting—Vincristine—sarcoma	0.000306	0.00389	CcSEcCtD
Prazosin—Rash—Vincristine—sarcoma	0.000304	0.00386	CcSEcCtD
Prazosin—Dermatitis—Vincristine—sarcoma	0.000304	0.00385	CcSEcCtD
Prazosin—Headache—Vincristine—sarcoma	0.000302	0.00383	CcSEcCtD
Prazosin—Epistaxis—Doxorubicin—sarcoma	0.000299	0.0038	CcSEcCtD
Prazosin—Vomiting—Mitoxantrone—sarcoma	0.000298	0.00379	CcSEcCtD
Prazosin—Rash—Mitoxantrone—sarcoma	0.000296	0.00376	CcSEcCtD
Prazosin—Dermatitis—Mitoxantrone—sarcoma	0.000296	0.00375	CcSEcCtD
Prazosin—CYP1A1—lymph node—sarcoma	0.000295	0.00353	CbGeAlD
Prazosin—Headache—Mitoxantrone—sarcoma	0.000294	0.00373	CcSEcCtD
Prazosin—ABCB1—uterus—sarcoma	0.000291	0.00349	CbGeAlD
Prazosin—Bradycardia—Doxorubicin—sarcoma	0.00029	0.00368	CcSEcCtD
Prazosin—Hypersensitivity—Etoposide—sarcoma	0.000288	0.00365	CcSEcCtD
Prazosin—Tinnitus—Epirubicin—sarcoma	0.000287	0.00365	CcSEcCtD
Prazosin—Nausea—Vincristine—sarcoma	0.000286	0.00363	CcSEcCtD
Prazosin—Flushing—Epirubicin—sarcoma	0.000286	0.00363	CcSEcCtD
Prazosin—Asthenia—Etoposide—sarcoma	0.00028	0.00356	CcSEcCtD
Prazosin—Nausea—Mitoxantrone—sarcoma	0.000279	0.00354	CcSEcCtD
Prazosin—Pruritus—Etoposide—sarcoma	0.000276	0.00351	CcSEcCtD
Prazosin—ADRA2A—lymph node—sarcoma	0.000275	0.00329	CbGeAlD
Prazosin—Alopecia—Epirubicin—sarcoma	0.000272	0.00346	CcSEcCtD
Prazosin—ABCB1—lymphoid tissue—sarcoma	0.000271	0.00325	CbGeAlD
Prazosin—Diarrhoea—Etoposide—sarcoma	0.000267	0.00339	CcSEcCtD
Prazosin—Tinnitus—Doxorubicin—sarcoma	0.000266	0.00337	CcSEcCtD
Prazosin—Flushing—Doxorubicin—sarcoma	0.000264	0.00336	CcSEcCtD
Prazosin—Tension—Epirubicin—sarcoma	0.000263	0.00334	CcSEcCtD
Prazosin—Nervousness—Epirubicin—sarcoma	0.00026	0.00331	CcSEcCtD
Prazosin—Dizziness—Etoposide—sarcoma	0.000258	0.00328	CcSEcCtD
Prazosin—Vision blurred—Epirubicin—sarcoma	0.000253	0.00321	CcSEcCtD
Prazosin—Alopecia—Doxorubicin—sarcoma	0.000252	0.0032	CcSEcCtD
Prazosin—Ill-defined disorder—Epirubicin—sarcoma	0.000249	0.00316	CcSEcCtD
Prazosin—Vomiting—Etoposide—sarcoma	0.000248	0.00315	CcSEcCtD
Prazosin—ABCB1—bone marrow—sarcoma	0.000247	0.00296	CbGeAlD
Prazosin—Rash—Etoposide—sarcoma	0.000246	0.00313	CcSEcCtD
Prazosin—Dermatitis—Etoposide—sarcoma	0.000246	0.00312	CcSEcCtD
Prazosin—Headache—Etoposide—sarcoma	0.000245	0.0031	CcSEcCtD
Prazosin—Tension—Doxorubicin—sarcoma	0.000243	0.00309	CcSEcCtD
Prazosin—Malaise—Epirubicin—sarcoma	0.000242	0.00307	CcSEcCtD
Prazosin—Nervousness—Doxorubicin—sarcoma	0.000241	0.00306	CcSEcCtD
Prazosin—Vertigo—Epirubicin—sarcoma	0.000241	0.00306	CcSEcCtD
Prazosin—Syncope—Epirubicin—sarcoma	0.00024	0.00305	CcSEcCtD
Prazosin—Palpitations—Epirubicin—sarcoma	0.000237	0.00301	CcSEcCtD
Prazosin—Loss of consciousness—Epirubicin—sarcoma	0.000236	0.00299	CcSEcCtD
Prazosin—Vision blurred—Doxorubicin—sarcoma	0.000234	0.00297	CcSEcCtD
Prazosin—Nausea—Etoposide—sarcoma	0.000232	0.00294	CcSEcCtD
Prazosin—Ill-defined disorder—Doxorubicin—sarcoma	0.00023	0.00292	CcSEcCtD
Prazosin—Arthralgia—Epirubicin—sarcoma	0.000228	0.0029	CcSEcCtD
Prazosin—Discomfort—Epirubicin—sarcoma	0.000226	0.00286	CcSEcCtD
Prazosin—Malaise—Doxorubicin—sarcoma	0.000224	0.00284	CcSEcCtD
Prazosin—Dry mouth—Epirubicin—sarcoma	0.000223	0.00283	CcSEcCtD
Prazosin—Vertigo—Doxorubicin—sarcoma	0.000223	0.00283	CcSEcCtD
Prazosin—Syncope—Doxorubicin—sarcoma	0.000222	0.00282	CcSEcCtD
Prazosin—Palpitations—Doxorubicin—sarcoma	0.000219	0.00278	CcSEcCtD
Prazosin—Oedema—Epirubicin—sarcoma	0.000219	0.00278	CcSEcCtD
Prazosin—Loss of consciousness—Doxorubicin—sarcoma	0.000218	0.00277	CcSEcCtD
Prazosin—Shock—Epirubicin—sarcoma	0.000215	0.00273	CcSEcCtD
Prazosin—Tachycardia—Epirubicin—sarcoma	0.000214	0.00271	CcSEcCtD
Prazosin—Hyperhidrosis—Epirubicin—sarcoma	0.000212	0.00269	CcSEcCtD
Prazosin—ABCB1—testis—sarcoma	0.000211	0.00253	CbGeAlD
Prazosin—Arthralgia—Doxorubicin—sarcoma	0.000211	0.00268	CcSEcCtD
Prazosin—Discomfort—Doxorubicin—sarcoma	0.000209	0.00265	CcSEcCtD
Prazosin—Dry mouth—Doxorubicin—sarcoma	0.000207	0.00262	CcSEcCtD
Prazosin—Oedema—Doxorubicin—sarcoma	0.000202	0.00257	CcSEcCtD
Prazosin—ABCB1—liver—sarcoma	0.0002	0.00239	CbGeAlD
Prazosin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000199	0.00253	CcSEcCtD
Prazosin—Shock—Doxorubicin—sarcoma	0.000199	0.00253	CcSEcCtD
Prazosin—Insomnia—Epirubicin—sarcoma	0.000198	0.00251	CcSEcCtD
Prazosin—Tachycardia—Doxorubicin—sarcoma	0.000198	0.00251	CcSEcCtD
Prazosin—Paraesthesia—Epirubicin—sarcoma	0.000196	0.00249	CcSEcCtD
Prazosin—Hyperhidrosis—Doxorubicin—sarcoma	0.000196	0.00249	CcSEcCtD
Prazosin—Dyspnoea—Epirubicin—sarcoma	0.000195	0.00248	CcSEcCtD
Prazosin—Somnolence—Epirubicin—sarcoma	0.000195	0.00247	CcSEcCtD
Prazosin—Fatigue—Epirubicin—sarcoma	0.000189	0.0024	CcSEcCtD
Prazosin—Pain—Epirubicin—sarcoma	0.000187	0.00238	CcSEcCtD
Prazosin—Constipation—Epirubicin—sarcoma	0.000187	0.00238	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000184	0.00234	CcSEcCtD
Prazosin—Insomnia—Doxorubicin—sarcoma	0.000183	0.00233	CcSEcCtD
Prazosin—Paraesthesia—Doxorubicin—sarcoma	0.000182	0.00231	CcSEcCtD
Prazosin—Dyspnoea—Doxorubicin—sarcoma	0.000181	0.00229	CcSEcCtD
Prazosin—Feeling abnormal—Epirubicin—sarcoma	0.00018	0.00229	CcSEcCtD
Prazosin—Somnolence—Doxorubicin—sarcoma	0.00018	0.00229	CcSEcCtD
Prazosin—Fatigue—Doxorubicin—sarcoma	0.000175	0.00222	CcSEcCtD
Prazosin—Urticaria—Epirubicin—sarcoma	0.000174	0.00221	CcSEcCtD
Prazosin—Pain—Doxorubicin—sarcoma	0.000173	0.0022	CcSEcCtD
Prazosin—Constipation—Doxorubicin—sarcoma	0.000173	0.0022	CcSEcCtD
Prazosin—Body temperature increased—Epirubicin—sarcoma	0.000173	0.0022	CcSEcCtD
Prazosin—Feeling abnormal—Doxorubicin—sarcoma	0.000167	0.00212	CcSEcCtD
Prazosin—Hypersensitivity—Epirubicin—sarcoma	0.000161	0.00205	CcSEcCtD
Prazosin—Urticaria—Doxorubicin—sarcoma	0.000161	0.00204	CcSEcCtD
Prazosin—Body temperature increased—Doxorubicin—sarcoma	0.00016	0.00203	CcSEcCtD
Prazosin—Asthenia—Epirubicin—sarcoma	0.000157	0.00199	CcSEcCtD
Prazosin—Pruritus—Epirubicin—sarcoma	0.000155	0.00197	CcSEcCtD
Prazosin—ABCB1—lymph node—sarcoma	0.000153	0.00184	CbGeAlD
Prazosin—Diarrhoea—Epirubicin—sarcoma	0.00015	0.0019	CcSEcCtD
Prazosin—Hypersensitivity—Doxorubicin—sarcoma	0.000149	0.00189	CcSEcCtD
Prazosin—Asthenia—Doxorubicin—sarcoma	0.000145	0.00184	CcSEcCtD
Prazosin—Dizziness—Epirubicin—sarcoma	0.000145	0.00184	CcSEcCtD
Prazosin—Pruritus—Doxorubicin—sarcoma	0.000143	0.00182	CcSEcCtD
Prazosin—Vomiting—Epirubicin—sarcoma	0.000139	0.00177	CcSEcCtD
Prazosin—Diarrhoea—Doxorubicin—sarcoma	0.000139	0.00176	CcSEcCtD
Prazosin—Rash—Epirubicin—sarcoma	0.000138	0.00175	CcSEcCtD
Prazosin—Dermatitis—Epirubicin—sarcoma	0.000138	0.00175	CcSEcCtD
Prazosin—Headache—Epirubicin—sarcoma	0.000137	0.00174	CcSEcCtD
Prazosin—Dizziness—Doxorubicin—sarcoma	0.000134	0.0017	CcSEcCtD
Prazosin—Nausea—Epirubicin—sarcoma	0.00013	0.00165	CcSEcCtD
Prazosin—Vomiting—Doxorubicin—sarcoma	0.000129	0.00163	CcSEcCtD
Prazosin—Rash—Doxorubicin—sarcoma	0.000128	0.00162	CcSEcCtD
Prazosin—Dermatitis—Doxorubicin—sarcoma	0.000128	0.00162	CcSEcCtD
Prazosin—Headache—Doxorubicin—sarcoma	0.000127	0.00161	CcSEcCtD
Prazosin—Nausea—Doxorubicin—sarcoma	0.00012	0.00153	CcSEcCtD
Prazosin—SLC22A2—Metabolism—PLCG1—sarcoma	2.53e-06	0.000767	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TLE1—sarcoma	2.52e-06	0.000764	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—CREB1—sarcoma	2.48e-06	0.000753	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—FLT1—sarcoma	2.48e-06	0.000753	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—IL2—sarcoma	2.47e-06	0.00075	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	2.46e-06	0.000748	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	2.45e-06	0.000745	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PLCG1—sarcoma	2.44e-06	0.00074	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	2.4e-06	0.000729	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PLCG1—sarcoma	2.35e-06	0.000715	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ENO2—sarcoma	2.35e-06	0.000714	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—HRAS—sarcoma	2.34e-06	0.000712	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCR4—sarcoma	2.34e-06	0.000711	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—HBA1—sarcoma	2.34e-06	0.00071	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ATF1—sarcoma	2.31e-06	0.000703	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFC—sarcoma	2.29e-06	0.000694	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—FLT1—sarcoma	2.24e-06	0.000679	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	2.21e-06	0.00067	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PLCG1—sarcoma	2.2e-06	0.000668	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—HRAS—sarcoma	2.18e-06	0.000663	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—FLT1—sarcoma	2.16e-06	0.000656	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	2.16e-06	0.000656	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—SRC—sarcoma	2.15e-06	0.000654	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFC—sarcoma	2.12e-06	0.000645	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PLCG1—sarcoma	2.12e-06	0.000645	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CREB1—sarcoma	2.12e-06	0.000644	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IGF1R—sarcoma	2.12e-06	0.000644	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCR4—sarcoma	2.11e-06	0.000642	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—VEGFA—sarcoma	2.1e-06	0.000637	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ATF1—sarcoma	2.09e-06	0.000634	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—NRAS—sarcoma	2.07e-06	0.000629	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—FLT1—sarcoma	2.06e-06	0.000625	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCR4—sarcoma	2.04e-06	0.000619	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.04e-06	0.000619	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ENO2—sarcoma	2.04e-06	0.000618	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—HBA1—sarcoma	2.02e-06	0.000614	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PLCG1—sarcoma	2.02e-06	0.000614	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—FOXO1—sarcoma	2.02e-06	0.000613	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—IL2—sarcoma	2.02e-06	0.000613	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ATF1—sarcoma	2.02e-06	0.000612	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PDGFRB—sarcoma	2.02e-06	0.000612	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PLCG1—sarcoma	2e-06	0.000606	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PDGFRA—sarcoma	1.98e-06	0.000603	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCR4—sarcoma	1.94e-06	0.00059	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ATF1—sarcoma	1.92e-06	0.000583	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CREB1—sarcoma	1.92e-06	0.000582	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—IL2—sarcoma	1.87e-06	0.000569	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CREB1—sarcoma	1.85e-06	0.000562	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL2—sarcoma	1.83e-06	0.000557	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—FLT1—sarcoma	1.83e-06	0.000555	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IGF1R—sarcoma	1.82e-06	0.000551	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.81e-06	0.000551	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PLCG1—sarcoma	1.8e-06	0.000545	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—KRAS—sarcoma	1.78e-06	0.000542	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CREB1—sarcoma	1.76e-06	0.000535	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—FOXO1—sarcoma	1.73e-06	0.000525	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—IL2—sarcoma	1.73e-06	0.000525	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PLCG1—sarcoma	1.73e-06	0.000525	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCR4—sarcoma	1.73e-06	0.000524	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PDGFRB—sarcoma	1.73e-06	0.000524	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ATF1—sarcoma	1.71e-06	0.000518	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PDGFRA—sarcoma	1.7e-06	0.000516	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FLT1—sarcoma	1.7e-06	0.000516	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—KDR—sarcoma	1.67e-06	0.000507	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PLCG1—sarcoma	1.67e-06	0.000507	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IGF1R—sarcoma	1.64e-06	0.000498	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—SRC—sarcoma	1.63e-06	0.000496	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ENO2—sarcoma	1.63e-06	0.000494	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—HBA1—sarcoma	1.62e-06	0.000491	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCR4—sarcoma	1.6e-06	0.000487	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—VEGFA—sarcoma	1.59e-06	0.000483	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ATF1—sarcoma	1.58e-06	0.000481	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TP53—sarcoma	1.58e-06	0.000481	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IGF1R—sarcoma	1.58e-06	0.000481	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—NRAS—sarcoma	1.57e-06	0.000477	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL2—sarcoma	1.57e-06	0.000476	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CREB1—sarcoma	1.56e-06	0.000475	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—FOXO1—sarcoma	1.56e-06	0.000474	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—IL2—sarcoma	1.56e-06	0.000474	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PDGFRB—sarcoma	1.56e-06	0.000473	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—KIT—sarcoma	1.54e-06	0.000467	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—NRAS—sarcoma	1.54e-06	0.000467	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PDGFRA—sarcoma	1.53e-06	0.000466	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—HRAS—sarcoma	1.52e-06	0.00046	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IGF1R—sarcoma	1.51e-06	0.000458	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—FOXO1—sarcoma	1.51e-06	0.000457	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—IL2—sarcoma	1.51e-06	0.000457	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PDGFRB—sarcoma	1.5e-06	0.000457	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PDGFRA—sarcoma	1.48e-06	0.00045	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CREB1—sarcoma	1.46e-06	0.000445	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CREB1—sarcoma	1.45e-06	0.000441	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—FOXO1—sarcoma	1.43e-06	0.000436	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—IL2—sarcoma	1.43e-06	0.000435	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PDGFRB—sarcoma	1.43e-06	0.000435	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KDR—sarcoma	1.43e-06	0.000434	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL2—sarcoma	1.42e-06	0.00043	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PDGFRA—sarcoma	1.41e-06	0.000428	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—EGFR—sarcoma	1.4e-06	0.000426	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PLCG1—sarcoma	1.38e-06	0.000419	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL2—sarcoma	1.37e-06	0.000415	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—KRAS—sarcoma	1.35e-06	0.000411	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IGF1R—sarcoma	1.34e-06	0.000407	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—KRAS—sarcoma	1.32e-06	0.000402	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KIT—sarcoma	1.32e-06	0.0004	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—NRAS—sarcoma	1.32e-06	0.0004	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL2—sarcoma	1.3e-06	0.000395	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KDR—sarcoma	1.29e-06	0.000392	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—FOXO1—sarcoma	1.27e-06	0.000387	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—IL2—sarcoma	1.27e-06	0.000387	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PDGFRB—sarcoma	1.27e-06	0.000386	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CREB1—sarcoma	1.25e-06	0.000381	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PDGFRA—sarcoma	1.25e-06	0.00038	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KDR—sarcoma	1.25e-06	0.000378	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IGF1R—sarcoma	1.24e-06	0.000378	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MDM2—sarcoma	1.21e-06	0.000368	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TP53—sarcoma	1.2e-06	0.000365	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—EGFR—sarcoma	1.2e-06	0.000364	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KIT—sarcoma	1.19e-06	0.000361	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—NRAS—sarcoma	1.19e-06	0.000361	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KDR—sarcoma	1.19e-06	0.00036	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FOXO1—sarcoma	1.18e-06	0.00036	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—IL2—sarcoma	1.18e-06	0.000359	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PDGFRB—sarcoma	1.18e-06	0.000359	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PDGFRA—sarcoma	1.16e-06	0.000353	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL2—sarcoma	1.16e-06	0.000351	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—HRAS—sarcoma	1.15e-06	0.000349	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KIT—sarcoma	1.15e-06	0.000349	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—NRAS—sarcoma	1.15e-06	0.000349	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—KRAS—sarcoma	1.13e-06	0.000344	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CREB1—sarcoma	1.13e-06	0.000344	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—HRAS—sarcoma	1.13e-06	0.000342	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KIT—sarcoma	1.09e-06	0.000332	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—NRAS—sarcoma	1.09e-06	0.000332	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CREB1—sarcoma	1.09e-06	0.000332	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—EGFR—sarcoma	1.08e-06	0.000329	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL2—sarcoma	1.08e-06	0.000329	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL2—sarcoma	1.07e-06	0.000326	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCND1—sarcoma	1.06e-06	0.000321	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KDR—sarcoma	1.05e-06	0.00032	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—JUN—sarcoma	1.05e-06	0.00032	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—EGFR—sarcoma	1.05e-06	0.000318	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CTNNB1—sarcoma	1.05e-06	0.000317	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CREB1—sarcoma	1.04e-06	0.000316	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MDM2—sarcoma	1.04e-06	0.000315	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—KRAS—sarcoma	1.02e-06	0.000311	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—EGFR—sarcoma	9.96e-07	0.000302	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—KRAS—sarcoma	9.88e-07	0.0003	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KDR—sarcoma	9.79e-07	0.000297	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KIT—sarcoma	9.71e-07	0.000295	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—NRAS—sarcoma	9.71e-07	0.000295	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—HRAS—sarcoma	9.63e-07	0.000293	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—SRC—sarcoma	9.45e-07	0.000287	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—KRAS—sarcoma	9.41e-07	0.000286	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MDM2—sarcoma	9.36e-07	0.000284	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL2—sarcoma	9.27e-07	0.000281	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CREB1—sarcoma	9.24e-07	0.000281	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VEGFA—sarcoma	9.2e-07	0.000279	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NRAS—sarcoma	9.09e-07	0.000276	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MDM2—sarcoma	9.04e-07	0.000275	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCND1—sarcoma	9.03e-07	0.000274	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KIT—sarcoma	9.02e-07	0.000274	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—NRAS—sarcoma	9.02e-07	0.000274	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—JUN—sarcoma	9.01e-07	0.000274	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CTNNB1—sarcoma	8.95e-07	0.000272	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—EGFR—sarcoma	8.84e-07	0.000269	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—HRAS—sarcoma	8.7e-07	0.000264	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MDM2—sarcoma	8.61e-07	0.000261	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CREB1—sarcoma	8.59e-07	0.000261	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MYC—sarcoma	8.47e-07	0.000257	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HRAS—sarcoma	8.4e-07	0.000255	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL2—sarcoma	8.37e-07	0.000254	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—KRAS—sarcoma	8.36e-07	0.000254	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EGFR—sarcoma	8.28e-07	0.000252	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—EGFR—sarcoma	8.22e-07	0.00025	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCND1—sarcoma	8.16e-07	0.000248	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—JUN—sarcoma	8.14e-07	0.000247	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SRC—sarcoma	8.09e-07	0.000246	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CTNNB1—sarcoma	8.08e-07	0.000245	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL2—sarcoma	8.08e-07	0.000245	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HRAS—sarcoma	8e-07	0.000243	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VEGFA—sarcoma	7.88e-07	0.000239	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCND1—sarcoma	7.87e-07	0.000239	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—JUN—sarcoma	7.86e-07	0.000239	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—KRAS—sarcoma	7.82e-07	0.000238	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CTNNB1—sarcoma	7.8e-07	0.000237	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NRAS—sarcoma	7.78e-07	0.000236	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—KRAS—sarcoma	7.76e-07	0.000236	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL2—sarcoma	7.69e-07	0.000234	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MDM2—sarcoma	7.65e-07	0.000232	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCND1—sarcoma	7.5e-07	0.000228	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—JUN—sarcoma	7.48e-07	0.000227	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CTNNB1—sarcoma	7.42e-07	0.000226	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SRC—sarcoma	7.3e-07	0.000222	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MYC—sarcoma	7.25e-07	0.00022	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VEGFA—sarcoma	7.11e-07	0.000216	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MDM2—sarcoma	7.1e-07	0.000216	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HRAS—sarcoma	7.1e-07	0.000216	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EGFR—sarcoma	7.09e-07	0.000215	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SRC—sarcoma	7.05e-07	0.000214	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NRAS—sarcoma	7.02e-07	0.000213	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—sarcoma	6.95e-07	0.000211	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VEGFA—sarcoma	6.86e-07	0.000208	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL2—sarcoma	6.83e-07	0.000207	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NRAS—sarcoma	6.78e-07	0.000206	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SRC—sarcoma	6.71e-07	0.000204	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KRAS—sarcoma	6.7e-07	0.000203	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCND1—sarcoma	6.66e-07	0.000202	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HRAS—sarcoma	6.65e-07	0.000202	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—JUN—sarcoma	6.65e-07	0.000202	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HRAS—sarcoma	6.6e-07	0.0002	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	6.6e-07	0.0002	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MYC—sarcoma	6.54e-07	0.000199	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VEGFA—sarcoma	6.54e-07	0.000199	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NRAS—sarcoma	6.46e-07	0.000196	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EGFR—sarcoma	6.4e-07	0.000194	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL2—sarcoma	6.35e-07	0.000193	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MYC—sarcoma	6.32e-07	0.000192	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCND1—sarcoma	6.19e-07	0.000188	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EGFR—sarcoma	6.18e-07	0.000188	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—JUN—sarcoma	6.17e-07	0.000188	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	6.13e-07	0.000186	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KRAS—sarcoma	6.04e-07	0.000184	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MYC—sarcoma	6.01e-07	0.000183	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SRC—sarcoma	5.96e-07	0.000181	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—sarcoma	5.95e-07	0.000181	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EGFR—sarcoma	5.88e-07	0.000179	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KRAS—sarcoma	5.84e-07	0.000177	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFA—sarcoma	5.81e-07	0.000176	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NRAS—sarcoma	5.73e-07	0.000174	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HRAS—sarcoma	5.69e-07	0.000173	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KRAS—sarcoma	5.56e-07	0.000169	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SRC—sarcoma	5.54e-07	0.000168	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFA—sarcoma	5.39e-07	0.000164	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—sarcoma	5.37e-07	0.000163	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MYC—sarcoma	5.34e-07	0.000162	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NRAS—sarcoma	5.33e-07	0.000162	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EGFR—sarcoma	5.22e-07	0.000159	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—sarcoma	5.19e-07	0.000158	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HRAS—sarcoma	5.14e-07	0.000156	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MYC—sarcoma	4.96e-07	0.000151	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HRAS—sarcoma	4.96e-07	0.000151	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—sarcoma	4.94e-07	0.00015	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KRAS—sarcoma	4.94e-07	0.00015	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EGFR—sarcoma	4.85e-07	0.000147	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HRAS—sarcoma	4.72e-07	0.000143	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KRAS—sarcoma	4.59e-07	0.000139	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—sarcoma	4.39e-07	0.000133	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HRAS—sarcoma	4.2e-07	0.000127	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—sarcoma	4.08e-07	0.000124	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HRAS—sarcoma	3.9e-07	0.000118	CbGpPWpGaD
